1. Structural basis for the inhibition of the HCoV-NL63 main protease Mpro by X77.
- Author
-
Xu, Jie, Zhu, Qinyao, Li, Wenwen, Yin, Xiushan, and Li, Jian
- Subjects
- *
INTESTINAL diseases , *CORONAVIRUSES , *CRYSTAL structure , *SARS-CoV-2 , *VIRAL replication - Abstract
Human coronaviruses are a group of pathogens that primarily cause respiratory and intestinal diseases. Infection can easily cause respiratory symptoms, as well as a variety of serious complications. There are several types of human coronaviruses, such as SARS-CoV, MERS-CoV, HCoV-229E, HCoV-OC43, HCoV-NL63, HCoV-HKU1, and SARS-CoV-2. The prevalence of COVID-19 has led to a growing focus on drug research against human coronaviruses. The main protease (Mpro) from human coronaviruses is a relatively conserved that controls viral replication. X77 was discovered to have extremely high inhibitory activity against SARS-CoV-2 Mpro through the use of computer-simulated docking. In this paper, we have resolved the crystal structure of the HCoV-NL63 Mpro complexed with X77 and analyzed their interaction in detail. This data provides essential information for solving their binding modes and their structural determinants. Then, we compared the binding modes of X77 with SARS-CoV-2 Mpro and HCoV-NL63 Mpro in detail. This study illustrates the structural basis of HCoV-NL63 Mpro binding to the inhibitor X77. The structural insights derived from this study will inform the development of new drugs with broad-spectrum resistance to human coronaviruses. • The crystal structure of X77 HCoV-NL63 Mpro in complex with inhibitor X77. • The structural basis of HCoV-NL63 Mpro binding to the inhibitor X77. • Structural comparison of X77 with SARS-CoV-2 Mpro and HCoV-NL63 Mpro. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF